Bioprocess Development Forum - Insights, Solutions, and Shortcuts in Bioprocessing

BioPharm Sponsored by Cytiva
  • Biopharma Trends
  • Upstream
  • Downstream
  • Regulatory/QbD

Regulatory/QbD

Subscribe to Enews Share This Page
Email Facebook Twitter

Top Picks

  • Considering Process Scaling for mAbs During Early Phase Development Monoclonal antibody processes must perform consistently across scales from hundreds of milliliters to thousands of liters.
  • Address the complexity of protein characterization Use Biacoreā„¢ surface plasmon resonance (SPR) systems for assessment of drug potency (EC50) and stability.

More in Regulatory/QbD

  • The Smart Benefit of Digital Systems in Preclinical Studies
  • Filtration methods to overcome new challenges in viral safety
  • Regulatory considerations for virus filtration process development
  • Quality Considerations for Using AI in Bio/Pharma

See All

Webcasts & Events

  • None currently featured.

See All

Knowledge Center


Principles & Methodology Handbooks  
Find practical tips and in-depth information about common methodologies used in the lab.

Visit the Library

Q&A with Industry Leaders


Top Tips for Successful Development of Antibody Chromatography Processes



Q&A Library

Related Content

  • eBook: recombinant protein chromatography process development
  • Considerations for smarter and faster process development
  • Q&A: Oligonucleotide synthesis in process development and scale-up
  • Comparison of Three Different Screening Techniques for Predicting Step Elution Conditions for a Cation Exchanger
  • On-demand webcast: Introducing Supor Prime filters
Home | Biopharma Trends | Upstream | Downstream | Regulatory/QbD | Terms of Use | Privacy Policy | About Us
BioPharm International | Pharmaceutical Technology
© 2025 MJH Associates. All rights reserved.